ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.

Guanqun Ge et al.PubMed ↗Publisher ↗

No numbers read from the abstract.